India’s move to cut Monsanto’s GMO cotton royalties may discourage biotech industry investment

pzkleyymno

India has cut the royalties that local seed companies pay to German drugmaker Bayer AG’s Monsanto unit for the third time in four years.

The decision could prompt Monsanto and other foreign seed companies to further scale back investment in the sector, said Ram Kaundinya, director general of the Federation of Seed Industry of India.

Prime Minister Narendra Modi’s government has decided to reduce royalties paid by Indian seed companies to Monsanto for its genetically modified (GM) cotton by 49 percent to 20 rupees for a packet of 450 grams, according to a farm ministry order. Before it was 39 rupees. The decision comes at a time when India’s cotton output is falling and needs a breakthrough to help maintain its leading position in the global cotton market.

“The order is most disappointing,” said Shivendra Bajaj, executive director of the alliance for Agri Innovation, an advocacy group. Other than cutting Monsanto’s royalties, the government raised the prices of GM cotton seeds by 1.43 percent to 710 rupees ($10.16) a packet.

Read full, original article: In fresh blow to Monsanto, India cuts GM cotton seed royalty

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT-Image-Jul-31-2026-07_35_35-AM
Wikipedia has assembled an informative list of fake news websites from across the ideological spectrum
png livestock cow cattle a
Consumer skepticism about gene-edited milk is neither fixed nor particularly high—and falls even more if it’s priced lower
Screenshot-2026-08-03-at-2.15.16-PM
Viewpoint: Trump’s relaxed controls on supplying China with microchips could undermine U.S. AI dominance
Screenshot-2026-08-03-at-2.25.49-PM
As measles vaccination rates collapse, scientists push for treatments long considered unnecessary
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-07-31-at-10.52.03-AM
Love sweets and fatty foods? You can blame your genes, but there are ways to quell the obsessions
ChatGPT Image Jul 29, 2026, 09_08_15 AM 2
The retreat of environmental extremism: Why activist NGOs are losing favor
Screenshot-2026-07-17-at-1.34.59-PM
Poll: Vaccine hesitancy soars when patients distrust health providers and turn to social media
ChatGPT Image Jul 29, 2026, 10_17_59 AM
Viewpoint: What does it mean when critics of conventional agriculture say many fruits and vegetables are “linked” to pesticide poisoning?
Screenshot-2026-08-03-at-2.06.39-PM
Viewpoint: Green energy supporters ‘fight back’ against conservative foundations backing  fossil fuel industry
ChatGPT Image Jul 31, 2026, 08_05_37 AM
With trust in RFK, Jr.'s CDC vaccine advice collapsing, physicians scramble to fill the information gap
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.